PI3 and hepatocellular carcinoma: We recently found that a three-CpG-based methylation signature based on peptidase inhibitor 3 (PI3), SCAN domain containing 3, and Src homology 3-domain growth factor receptor-bound 2-like interacting protein 1 could predict recurrence in patients with early-stage HCC after surgery [10].